Sex and Cardiovascular Involvement in Inflammatory Joint Diseases

Santos Castañeda1,2, Carlos González-Juanatey3, Miguel A González-Gay4

  • 1Rheumatology Division, Hospital de La Princesa, IIS-Princesa, c/Diego de León 62, 28006, Madrid, Spain. scastas@gmail.com.

Insights

Men with inflammatory joint disease (IJD) face higher cardiovascular risks, including heart failure and mortality. Women with IJD experience different heart issues, like diastolic dysfunction. More research is needed on sex differences in IJD cardiovascular complications.

Area of Science:

  • Rheumatology
  • Cardiology
  • Sex-based Medicine

Background:

  • Inflammatory joint diseases (IJD) increase cardiovascular (CV) disease risk.
  • The specific impact of sex on CV complications in IJD remains under-explored.

Purpose of the Study:

  • To evaluate how sex influences the clinical presentation of CV manifestations in patients with IJD.
  • To update current knowledge on sex-based CV risk differences in IJD.

Main Methods:

  • A literature review was conducted using the PubMed database.
  • Focus on studies published in English within the last 10 years, primarily addressing sex differences in CV complications of IJD.

Main Results:

  • Men with rheumatoid arthritis (RA) show higher risks of pericarditis, ischemic heart disease, heart failure with reduced ejection fraction (EF), and CV mortality compared to women with RA.
  • Women with RA are more prone to heart failure with preserved EF and diastolic dysfunction.
  • Men with ankylosing spondylitis exhibit more conduction system disorders and aortic valvulopathy than women.

Conclusions:

  • Sex influences the clinical expression of CV complications in inflammatory joint diseases.
  • Further research is essential to fully understand the role of sex in CV disease risk stratification for IJD patients.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
607
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
748
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
605
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
633
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
17.3K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
973